Axon Enterprise, Inc $AXON Shares Acquired by Clearbridge Investments LLC

Clearbridge Investments LLC raised its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 21.1% in the fourth quarter, Holdings Channel.com reports. The fund owned 343,910 shares of the biotechnology company’s stock after acquiring an additional 59,821 shares during the quarter. Clearbridge Investments LLC’s holdings in Axon Enterprise were worth $195,317,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in AXON. Brighton Jones LLC acquired a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $480,000. NewEdge Advisors LLC raised its holdings in shares of Axon Enterprise by 41.1% during the first quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock valued at $1,207,000 after acquiring an additional 668 shares during the last quarter. Empowered Funds LLC raised its holdings in shares of Axon Enterprise by 8.4% during the first quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock valued at $1,067,000 after acquiring an additional 157 shares during the last quarter. Woodline Partners LP raised its holdings in shares of Axon Enterprise by 40.6% during the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock valued at $3,646,000 after acquiring an additional 2,003 shares during the last quarter. Finally, Sivia Capital Partners LLC acquired a new position in shares of Axon Enterprise during the second quarter valued at approximately $284,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insiders Place Their Bets

In related news, Director Jeri Williams sold 629 shares of Axon Enterprise stock in a transaction on Monday, June 1st. The stock was sold at an average price of $469.64, for a total value of $295,403.56. Following the completion of the transaction, the director directly owned 1,141 shares in the company, valued at approximately $535,859.24. This trade represents a 35.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $400.00, for a total value of $800,000.00. Following the completion of the transaction, the insider owned 52,813 shares of the company’s stock, valued at approximately $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 3,548 shares of company stock valued at $1,542,775. 4.20% of the stock is currently owned by insiders.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $486.12 on Monday. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The stock has a market cap of $39.18 billion, a PE ratio of 195.23, a P/E/G ratio of 8.84 and a beta of 1.45. The stock has a 50 day moving average price of $408.04 and a 200 day moving average price of $491.56.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.91 million. During the same quarter last year, the firm earned $1.47 earnings per share. The business’s revenue for the quarter was up 33.7% on a year-over-year basis. Equities research analysts expect that Axon Enterprise, Inc will post 1.82 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Wall Street Zen raised Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Zacks Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 19th. Craig Hallum reaffirmed a “buy” rating and issued a $820.00 price target on shares of Axon Enterprise in a report on Wednesday, February 25th. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. Finally, UBS Group cut their price target on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating for the company in a report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $712.75.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.